{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:49:58Z","timestamp":1788821398915,"version":"build-2803163510"},"reference-count":110,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Introduction: Chronic Kidney Disease (CKD) is a leading public health problem worldwide, with limited therapeutic options to halt its progression. Recent evidence implicates non-coding RNAs (ncRNAs), specifically long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), as critical regulators in renal pathophysiology and the transition from Acute Kidney Injury (AKI) to CKD. This review aims to synthesize recent findings regarding the role of ncRNAs in CKD pathogenesis, emphasizing their potential as diagnostic biomarkers and therapeutic targets. Methods: A systematic search was conducted in the PubMed\/MEDLINE and Scopus databases for original research articles published over the last five years. Studies were selected based on specific eligibility criteria focusing on the correlation of ncRNAs with the development, diagnosis, and therapy of CKD. A total of 14 studies were included in the final review. Results: This review identified a dual landscape of ncRNAs function. Several lncRNAs, including H19, MALAT1, NEAT1_2, and LINC00963, were found to act as pathogenic drivers, promoting inflammation, apoptosis, and fibrosis through pathways such as TGF-\u03b2\/Smad and NF-\u03baB. Specifically, MALAT1 and NEAT1_2 are pivotal in driving the AKI-to-CKD transition. Conversely, specific miRNAs, such as miR-204, miR-26a, miR-451, miR-101, and miR-486-5p, exhibited protective effects by attenuating oxidative stress, preserving endothelial function, and inhibiting epithelial\u2013mesenchymal transition (EMT). Dysregulation of these molecules was also observed in systemic conditions affecting the kidney, such as congestive heart failure and \u03b2-thalassemia. Conclusions: ncRNAs are central players in the molecular mechanisms underlying renal injury and maladaptive repair. The identified lncRNAs and miRNAs offer promising avenues for non-invasive diagnosis and the development of novel targeted therapies to prevent fibrosis and slow the progression of CKD.<\/jats:p>","DOI":"10.3390\/life16040579","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:09:54Z","timestamp":1775138994000},"page":"579","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long Non-Coding RNAs and Micro RNAs in Chronic Kidney Disease: Recent Advances and Future Directions\u2014A 5-Year Systematic Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0194-1339","authenticated-orcid":false,"given":"Kanellos","family":"Skourtsidis","sequence":"first","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Laboratory of Histology-Embryology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5676-4045","authenticated-orcid":false,"given":"Despoina","family":"Ioannou","sequence":"additional","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Laboratory of Histology-Embryology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2868-8644","authenticated-orcid":false,"given":"Georgios","family":"Kiosis","sequence":"additional","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Laboratory of Histology-Embryology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0816-6066","authenticated-orcid":false,"given":"Konstantinos","family":"Stergiou","sequence":"additional","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Laboratory of Histology-Embryology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1829-4735","authenticated-orcid":false,"given":"Maria Nefeli","family":"Georgaki","sequence":"additional","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Environmental Engineering Laboratory (EnvE-Lab), Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0709-5407","authenticated-orcid":false,"given":"Theodora","family":"Papamitsou","sequence":"additional","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Laboratory of Histology-Embryology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-8410","authenticated-orcid":false,"given":"Sofia","family":"Karachrysafi","sequence":"additional","affiliation":[{"name":"Research Team \u201cHistologistas\u201d, Interinstitutional Postgraduate Program \u201cHealth and Environmental Factors\u201d, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"},{"name":"Laboratory of Histology-Embryology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"s03","DOI":"10.1590\/1806-9282.66.s1.3","article-title":"Chronic Kidney Disease","volume":"66","author":"Ammirati","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccc.2020.11.013","article-title":"Acute Kidney Disease to Chronic Kidney Disease","volume":"37","author":"Neyra","year":"2021","journal-title":"Crit. Care Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Deng, L., Guo, S., Liu, Y., Zhou, Y., Liu, Y., Zheng, X., Yu, X., and Shuai, P. (2025). Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021. BMC Public Health, 25.","DOI":"10.1186\/s12889-025-21851-z"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Qi, Q., Hu, Y., Shen, Q., Tang, K., Yu, J., Xu, Y., Huang, Q., Hou, B., and Hao, Z. (2025). Global, regional, and national burden of chronic kidney disease and its associated anemia, 1990 to 2021 and predictions to 2050: An analysis of the global burden of disease study 2021. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04398-4"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Guo, J., Jiao, W., Xia, S., Xiang, X., Zhang, Y., Ge, X., and Sun, Q. (2025). The global, regional, and national patterns of change in the burden of chronic kidney disease from 1990 to 2021. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04028-z"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Cherney","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: A review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_8","first-page":"100822","article-title":"A critical review of chronic kidney disease as a risk factor for coronary artery disease","volume":"35","author":"Coyle","year":"2021","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mallamaci, F., and Tripepi, G. (2024). Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030678"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/kisup.2013.79","article-title":"Risk factors for chronic kidney disease: An update","volume":"3","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","article-title":"Hypertension in chronic kidney disease-treatment standard 2023","volume":"38","author":"Georgianos","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"(2021). Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int., 99, S1\u2013S87.","DOI":"10.1016\/j.kint.2020.11.003"},{"key":"ref_13","first-page":"7S","article-title":"Diabetes mellitus and hypertension: Key risk factors for kidney disease","volume":"94","author":"Lea","year":"2002","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4093\/dmj.2020.0109","article-title":"High Incidence of Chronic Kidney Disease among Iranian Diabetic Adults: Using CKD-EPI and MDRD Equations for Estimated Glomerular Filtration Rate","volume":"45","author":"Moazzeni","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ndt\/gfac285","article-title":"Clinical implications and guidelines for CKD in type 2 diabetes","volume":"38","author":"Zhang","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","article-title":"Obesity and chronic kidney disease","volume":"324","author":"Jiang","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2215\/CJN.0000000704","article-title":"Obesity and Metabolic Health in CKD","volume":"20","author":"Kovesdy","year":"2025","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Longhitano, E., Calabrese, V., Casuscelli, C., Di Carlo, S., Maltese, S., Romeo, A., Calanna, M., Conti, G., and Santoro, D. (2024). Proteinuria and Progression of Renal Damage: The Main Pathogenetic Mechanisms and Pharmacological Approach. Medicina, 60.","DOI":"10.3390\/medicina60111821"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9613062","DOI":"10.1155\/2022\/9613062","article-title":"Risk Factors for Progression of CKD with and without Diabetes","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Diabetes Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kochan, Z., Szupryczynska, N., Malgorzewicz, S., and Karbowska, J. (2021). Dietary Lipids and Dyslipidemia in Chronic Kidney Disease. Nutrients, 13.","DOI":"10.3390\/nu13093138"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2020030384","article-title":"Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis","volume":"32","author":"Kelly","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"26511","DOI":"10.1038\/s41598-024-72685-5","article-title":"Environmental factors and chronic kidney disease: A case-control study","volume":"14","author":"Fararouei","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ghelichi-Ghojogh, M., Fararouei, M., Seif, M., and Pakfetrat, M. (2022). Chronic kidney disease and its health-related factors: A case-control study. BMC Nephrol., 23.","DOI":"10.1186\/s12882-021-02655-w"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: Are They Safe?","volume":"76","author":"Baker","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s12325-023-02481-6","article-title":"Non-steroidal Anti-inflammatory Drugs: Clinical Implications, Renal Impairment Risks, and AKI","volume":"40","author":"LaForge","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000516647","article-title":"Defining AKD: The Spectrum of AKI, AKD, and CKD","volume":"146","author":"Levey","year":"2022","journal-title":"Nephron"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40620-020-00793-2","article-title":"AKI: An increasingly recognized risk factor for CKD development and progression","volume":"33","author":"Kurzhagen","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","article-title":"Conference Participants. Harmonizing acute and chronic kidney disease definition and classification: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"100","author":"Lameire","year":"2021","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-023-05969-9","article-title":"The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis","volume":"14","author":"Guo","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","article-title":"Mitochondrial dysfunction and the AKI-to-CKD transition","volume":"319","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"122509","DOI":"10.1016\/j.lfs.2024.122509","article-title":"Significance of LncRNAs in AKI-to-CKD transition: A therapeutic and diagnostic viewpoint","volume":"342","author":"Puri","year":"2024","journal-title":"Life Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123836","DOI":"10.1016\/j.lfs.2025.123836","article-title":"From AKI to CKD: Role of miRNAs in disease progression","volume":"378","author":"Bedin","year":"2025","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and Mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-7231-9_2","article-title":"RNA Function Prediction","volume":"1654","author":"Li","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/bs.pmbts.2025.01.001","article-title":"Dissecting ncRNA pathways and omics integration","volume":"214","author":"Agu","year":"2025","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41581-022-00608-6","article-title":"MicroRNAs in kidney injury and disease","volume":"18","author":"Mahtal","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCRESAHA.122.321939","article-title":"Circulating Extracellular Vesicle-Propagated microRNA Signature as a Vascular Calcification Factor in Chronic Kidney Disease","volume":"132","author":"Koide","year":"2023","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ymthe.2019.02.009","article-title":"MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells","volume":"27","author":"Liu","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"C292","DOI":"10.1152\/ajpcell.00382.2021","article-title":"LncRNA NEAT1 accelerates renal fibrosis progression via targeting miR-31 and modulating RhoA\/ROCK signal pathway","volume":"324","author":"Chen","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"155783","DOI":"10.1016\/j.prp.2024.155783","article-title":"LncRNA MALAT1 as a potential diagnostic and therapeutic target in kidney diseases","volume":"266","author":"Puri","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1089\/dna.2021.0627","article-title":"Exploring the Role of CircRNA in Diabetic Kidney Disease from a Novel Perspective: Focusing on Both Glomeruli and Tubuli","volume":"40","author":"Liu","year":"2021","journal-title":"DNA Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41581-021-00465-9","article-title":"Circular RNAs in kidney disease and cancer","volume":"17","author":"Bijkerk","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbadis.2016.10.027","article-title":"microRNAs in the pathophysiology of CKD-MBD: Biomarkers and innovative drugs","volume":"1863","author":"Burtey","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108709","DOI":"10.1016\/j.pharmthera.2024.108709","article-title":"microRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential","volume":"262","author":"Liu","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107044","DOI":"10.1016\/j.ejps.2025.107044","article-title":"CRISPR\/Cas9 based knockout of lncRNA MALAT1 attenuates TGF-\u03b21 induced Smad 2\/3 mediated fibrosis during AKI-to-CKD transition","volume":"207","author":"Puri","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.omtn.2022.03.001","article-title":"Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy","volume":"28","author":"Wang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/15384101.2022.2064957","article-title":"A long non-coding RNA H19\/microRNA-138\/TLR3 network is involved in high phosphorus-mediated vascular calcification and chronic kidney disease","volume":"21","author":"Liu","year":"2022","journal-title":"Cell Cycle"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10157-021-02023-w","article-title":"Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease","volume":"25","author":"Okuyan","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e23881","DOI":"10.1002\/jcla.23881","article-title":"Knockdown of lncRNA MALAT1 ameliorates acute kidney injury by mediating the miR-204\/APOL1 pathway","volume":"35","author":"Lu","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.ymthe.2022.05.019","article-title":"Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p","volume":"30","author":"Ma","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12950-021-00293-5","article-title":"Downregulation of lncRNA-PVT1 participates in the development of progressive chronic kidney disease among patients with congestive heart failure","volume":"18","author":"Chang","year":"2021","journal-title":"J. Inflamm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1111\/jcmm.15211","article-title":"LINC00963 targeting miR-128-3p promotes acute kidney injury process by activating JAK2\/STAT1 pathway","volume":"24","author":"Xie","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e41202","DOI":"10.1097\/MD.0000000000041202","article-title":"MicroRNA-204 may predict the renal function in patients with chronic kidney disease","volume":"104","author":"Guo","year":"2025","journal-title":"Medicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"16499","DOI":"10.1038\/s41598-021-94984-x","article-title":"miR-141 mediates recovery from acute kidney injury","volume":"11","author":"Newbury","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/CM9.0000000000002978","article-title":"Therapeutic role of miR-26a on cardiorenal injury in a mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1\/ILK pathway","volume":"138","author":"Ni","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_57","first-page":"188","article-title":"The Association Between Plasma MicroRNA-451 Expression Levels and Chronic Kidney Disease in Children with \u03b2-Thalassemia Major","volume":"16","author":"Ahmed","year":"2022","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e24358","DOI":"10.1002\/jcla.24358","article-title":"Clinical value of serum miR-320-3p expression in predicting the prognosis of sepsis-induced acute kidney injury","volume":"36","author":"Ji","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1177\/0960327120937334","article-title":"Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition","volume":"39","author":"Zhao","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/CS20231752","article-title":"miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction","volume":"138","author":"Douvris","year":"2024","journal-title":"Clin. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid. Synth."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.apsb.2016.02.004","article-title":"The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s11255-021-02905-8","article-title":"LncRNA PVT1 accelerates LPS-induced septic acute kidney injury through targeting miR-17-5p and regulating NF-\u03baB pathway","volume":"53","author":"Yuan","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"C1387","DOI":"10.1152\/ajpcell.00382.2023","article-title":"MicroRNA-138: An emerging regulator of skeletal development, homeostasis, and disease","volume":"325","author":"Brito","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Yang, L., Wang, B., Ma, L., and Fu, P. (2022). An Update of Long-Noncoding RNAs in Acute Kidney Injury. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.849403"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154908","DOI":"10.1016\/j.prp.2023.154908","article-title":"Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review","volume":"252","author":"Hussain","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm.4135","article-title":"p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity","volume":"22","author":"Adriaens","year":"2016","journal-title":"Nat. Med."},{"key":"ref_68","first-page":"3478","article-title":"LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145\/ZEB2 axis","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Zhang, J., Han, C., Song, K., Chen, W., Ungerleider, N., Yao, L., Ma, W., and Wu, T. (2020). The long-noncoding RNA MALAT1 regulates TGF-\u03b2\/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228160"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00240-021-01286-y","article-title":"MicroRNA-204 attenuates oxidative stress damage of renal tubular epithelial cells in calcium oxalate kidney-stone formation via MUC4-mediated ERK signaling pathway","volume":"50","author":"Xie","year":"2022","journal-title":"Urolithiasis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/a-0630-0173","article-title":"MicroRNA-204-3p Attenuates High Glucose-Induced MPC5 Podocytes Apoptosis by Targeting Braykinin B2 Receptor","volume":"127","author":"Han","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2215\/CJN.12181214","article-title":"GFR in Patients with \u03b2-Thalassemia Major","volume":"10","author":"Milo","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.amjms.2021.02.011","article-title":"MicroRNAs in \u03b2-thalassemia","volume":"362","author":"Wang","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.febslet.2011.07.042","article-title":"MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy","volume":"586","author":"Zhang","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2215\/CJN.00850122","article-title":"The Pathophysiology of Sepsis-Associated AKI","volume":"17","author":"Kuwabara","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00018-021-04104-1","article-title":"Integrin-linked kinase (ILK): The known vs. the unknown and perspectives","volume":"79","author":"Mazur","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney fibrosis","volume":"21","author":"Liu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2316259","DOI":"10.1080\/0886022X.2024.2316259","article-title":"Kr\u00fcppel-like factor 4 modulates the miR-101\/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial-mesenchymal transition","volume":"46","author":"Zhao","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/ijmm.2021.4952","article-title":"MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-\u03b21 type I receptor","volume":"47","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"15593258221083486","DOI":"10.1177\/15593258221083486","article-title":"Dexmedetomidine Protects Against Kidney Fibrosis in Diabetic Mice by Targeting miR-101-3p-Mediated EndMT","volume":"20","author":"Song","year":"2022","journal-title":"Dose Response"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00018-022-04406-y","article-title":"miRNA-486-5p: Signaling targets and role in non-malignant disease","volume":"79","author":"Douvris","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1871520621666210419093652","article-title":"Hindering the Synchronization Between miR-486-5p and H19 lncRNA by Hesperetin Halts Breast Cancer Aggressiveness Through Tuning ICAM-1","volume":"22","author":"Abdallah","year":"2022","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Cavallari, I., Ciccarese, F., Sharova, E., Urso, L., Raimondi, V., Silic-Benussi, M., D\u2019Agostino, D.M., and Ciminale, V. (2021). The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers, 13.","DOI":"10.3390\/cancers13235874"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.7150\/jca.55626","article-title":"LINC01296\/miR-141-3p\/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process","volume":"12","author":"Sun","year":"2021","journal-title":"J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41434-020-0160-x","article-title":"LncRNA SNHG16 induces proliferation and fibrogenesis via modulating miR-141-3p and CCND1 in diabetic nephropathy","volume":"27","author":"Jiang","year":"2020","journal-title":"Gene Ther."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ijmm.2014.2008","article-title":"miR-141 regulates TGF-\u03b21-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells","volume":"35","author":"Huang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Shi, S., Song, L., Yu, H., Feng, S., He, J., Liu, Y., and He, Y. (2020). Knockdown of LncRNA-H19 Ameliorates Kidney Fibrosis in Diabetic Mice by Suppressing miR-29a-Mediated EndMT. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.586895"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"51473","DOI":"10.18632\/oncotarget.10444","article-title":"Long non-coding RNA-H19 antagonism protects against renal fibrosis","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wang, B., Suen, C.W., Ma, H., Wang, Y., Kong, L., Qin, D., Lee, Y.W.W., and Li, G. (2020). The Roles of H19 in Regulating Inflammation and Aging. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.579687"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1038\/s41598-018-21720-3","article-title":"Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia\/reperfusion-injury","volume":"8","author":"Genschel","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Huang, H., Zhang, G., and Ge, Z. (2021). lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p\/IL6ST Axis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.647650"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"F93","DOI":"10.1152\/ajprenal.00552.2019","article-title":"Long noncoding RNA NEAT1 sponges miR-129 to modulate renal fibrosis by regulation of collagen type I","volume":"319","author":"Li","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/med-2020-0401","article-title":"NEAT1 aggravates sepsis-induced acute kidney injury by sponging miR-22-3p","volume":"15","author":"Feng","year":"2020","journal-title":"Open Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1007\/s10238-023-01191-1","article-title":"The mechanisms and therapeutic potential of long noncoding RNA NEAT1 in fibrosis","volume":"23","author":"Jiang","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1681\/ASN.2019101100","article-title":"Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes","volume":"31","author":"Cheng","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.kint.2021.05.034","article-title":"micro-RNA-486-5p protects against kidney ischemic injury and modifies the apoptotic transcriptome in proximal tubules","volume":"100","author":"Spence","year":"2021","journal-title":"Kidney Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ncrna.2025.06.003","article-title":"Serum lncRNAs NEAT1, PVT1 and H19 as novel biomarkers for sarcopenia diagnosis and treatment response","volume":"14","author":"Aparicio","year":"2025","journal-title":"Noncoding RNA Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e16057","DOI":"10.7717\/peerj.16057","article-title":"Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO","volume":"11","author":"Su","year":"2023","journal-title":"PeerJ"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.21037\/tcr-21-1385","article-title":"Relationship between miR-204 and ANGPTL2 expression and diagnosis, pathological stage, and prognosis in patients with colon cancer","volume":"10","author":"Wang","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1038\/s41598-022-13430-8","article-title":"Circulating miR-141 as a potential biomarker for diagnosis, prognosis and therapeutic targets in gallbladder cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7754\/Clin.Lab.2020.200612","article-title":"Exosomal miR-23a and miR-192, Potential Diagnostic Biomarkers for Type 2 Diabetes","volume":"67","author":"Liu","year":"2021","journal-title":"Clin. Lab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.juro.2013.07.001","article-title":"Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer","volume":"190","author":"Ren","year":"2013","journal-title":"J. Urol."},{"key":"ref_103","first-page":"923","article-title":"Long chain non-coding RNA MALAT-1 gene knockdown inhibits growth and migration and promotes apoptosis of human laryngeal squamous cell carcinoma Hep-2 cells in vitro","volume":"38","author":"Han","year":"2018","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13941","DOI":"10.18632\/aging.203004","article-title":"NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib","volume":"13","author":"Gu","year":"2021","journal-title":"Aging"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"194921","DOI":"10.1016\/j.bbagrm.2023.194921","article-title":"Novel splice variants of LINC00963 suppress colorectal cancer cell proliferation via miR-10a\/miR-143\/miR-217\/miR-512-mediated regulation of PI3K\/AKT and Wnt\/\u03b2-catenin signaling pathways","volume":"1866","author":"Ghaemi","year":"2023","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2147\/OTT.S241199","article-title":"miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a","volume":"13","author":"Li","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/2211536610666210910130828","article-title":"An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis","volume":"10","author":"Soofiyani","year":"2021","journal-title":"MicroRNA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/cam4.1016","article-title":"MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma","volume":"6","author":"Xu","year":"2017","journal-title":"Cancer Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1186\/s12951-024-02830-9","article-title":"S-RBD-modified and miR-486-5p-engineered exosomes derived from mesenchymal stem cells suppress ferroptosis and alleviate radiation-induced lung injury and long-term pulmonary fibrosis","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/4\/579\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:22:20Z","timestamp":1775139740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/4\/579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":110,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["life16040579"],"URL":"https:\/\/doi.org\/10.3390\/life16040579","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}